Cilomilast: A breath of relief?

Trends in Molecular Medicine

Volumn 7, Issue 10, 2001, Pages 433-434

  Giembycz, Mark A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CILOMILAST; PHOSPHODIESTERASE IV INHIBITOR; PLACEBO; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; NAUSEA; NOTE; PEAK EXPIRATORY FLOW; QUALITY OF LIFE; SMOKING CESSATION; VITAL CAPACITY; VOMITING;

EID: 0034792886     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(01)02156-6     Document Type: Short Survey

References (3)

1. Cilomilast (SB 207499, Ariflo™), a novel selective phosphodiesterase 4 inhibitor for the treatment of patients with chronic obstructive pulmonary disease: A randomised dose-ranging study
2. Cilomilast: A second-generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease
3. Synthesis, structure-activity relationships, and pharmacological profile of 9-amino-4-oxo-1-phenyl-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indoles: Discovery of potent, selective phosphodiesterase type 4 inhibitors